United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2006_register
executive
2010-09-22
article
Prospective Grant of Exclusive License: FDA Approvable Human DNA Diagnostic Test for Endometriosis
Notices
D09002ee1bde25118
D09002ee1bde251e6
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
National Institutes of Health
originator
org
United States Government Agency or Subagency
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license worldwide to practice the invention embodied in U.S. Patent Application Number 60/654,331 filed February 18, 2005, entitled ``Identification of Molecular Markers for Endometriosis in Blood Lymphocytes Using DNA Microarrays,'' to Ortho-Clinical Diagnostics, having a place of business in Raritan, NJ 08869. The contemplated exclusive license may be limited to an FDA approvable human DNA diagnostic test for endometriosis. The United States of America is the assignee of the patent rights in this invention.
71 FR 5345
https://www.govinfo.gov/app/details/FR-2006-02-01/E6-1277
E6-1277
fr01fe06-102
4140-01-P
https://www.govinfo.gov/app/details/FR-2006-02-01/E6-1277
https://www.govinfo.gov/content/pkg/FR-2006-02-01/html/E6-1277.htm
https://www.govinfo.gov/content/pkg/FR-2006-02-01/pdf/E6-1277.pdf
2 p.
5345
5346
71 FR 5345
Prospective Grant of Exclusive License: FDA Approvable Human DNA Diagnostic Test for Endometriosis; Federal Register Vol. 71, Issue
NOTICE
E6-1277
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
2006-04-03
4140-01-P
E6-1277
Notice.
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license worldwide to practice the invention embodied in U.S. Patent Application Number 60/654,331 filed February 18, 2005, entitled ``Identification of Molecular Markers for Endometriosis in Blood Lymphocytes Using DNA Microarrays,'' to Ortho-Clinical Diagnostics, having a place of business in Raritan, NJ 08869. The contemplated exclusive license may be limited to an FDA approvable human DNA diagnostic test for endometriosis. The United States of America is the assignee of the patent rights in this invention.
Only written comments and/or application for a license which are received by the National Institutes of Health on or before April 3, 2006 will be considered.
Inventions, Government-owned; availability for licensing,
ms482m@nih.gov
Federal Register
Vol. 71, no. 21
Office of the Federal Register, National Archives and Records Administration
2006-02-01
continuing
daily
deposited
born digital
433 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2006-02-01
P0b002ee180969686
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr01fe06
https://www.govinfo.gov/app/details/FR-2006-02-01
https://www.govinfo.gov/content/pkg/FR-2006-02-01/pdf/FR-2006-02-01.pdf
https://www.govinfo.gov/content/pkg/FR-2006-02-01/xml/FR-2006-02-01.xml
fdlp
5155
5578
DGPO
2010-09-22
2023-05-03
FR-2006-02-01
machine generated
eng
FR
FR-2006-02-01
71
21